Home › Funds › Candriam S.C.A. › RVMD

Candriam S.C.A. position in RVMD

REVOLUTION MEDICINES INC · Health Care

Candriam S.C.A. reported holding 445,693 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$91.8M, representing 0.41% of its reported portfolio and ranking #46 among its reported holdings. Candriam S.C.A. has disclosed RVMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)445.69K sh
Reported value held$91.82M
Portfolio Weight0.41%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Candriam S.C.A.'s RVMD position evolved

Candriam S.C.A. first disclosed a stake in RVMD in Q3 2023 at 561,948 shares (US$15.6M). The position peaked in Q2 2026 at 556,392 shares, worth US$104.1M. Across 13 filings, Candriam S.C.A. increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 445,693 shares valued at US$91.8M — a reduction of -110,699 shares quarter over quarter.. Notable position changes include a 44% trim in Q1 2026 (shares rose 93% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 561.95K $15.55M New
Q4 2023 606.95K $17.41M Add
Q1 2024 583.95K $18.82M Reduce
Q2 2024 554.33K $21.51M Reduce
Q3 2024 563.78K $25.57M Add
Q4 2024 656.74K $28.73M Add
Q1 2025 655.13K $23.17M Hold
Q2 2025 719.51K $26.47M Add
Q3 2025 868.72K $40.57M Add
Q4 2025 1.03M $82.12M Add
Q1 2026 580.68K $56.47M Reduce
Q2 2026 556.39K $104.10M Reduce
Q3 2026 445.69K $91.82M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 58 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Candriam S.C.A. held RVMD?

Candriam S.C.A. has disclosed RVMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Candriam S.C.A.'s current position in RVMD?

As of Q3 2026, Candriam S.C.A. holds 445.69K shares of RVMD (REVOLUTION MEDICINES INC), valued at $91.82M, representing 0.41% of its reported portfolio and ranking #46.

Has Candriam S.C.A. been buying or selling RVMD?

In the latest 13F filing (Q3 2026), Candriam S.C.A. reduced its position in RVMD. The position peaked in Q2 2026 at 556.39K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.